☏ +1 650 501 5505 [email protected]

Industry practice

In-Vitro Diagnostics Market Research & Consulting

The in-vitro diagnostics practice covers assays, instruments, reagents and laboratory testing markets. Markets are sized from test volumes and instrument installed base, with reagent pricing evidenced from tenders and procurement records.

Fixed fee engagements Bottom-up sector models 2025 base year, 2035 horizon

Coverage

What the In-Vitro Diagnostics practice covers

IVD is a razor-and-blade sector: instruments place the base and reagents earn the revenue, so models here track both sides separately. Test volumes, automation adoption and laboratory consolidation are the standing demand drivers across the coverage.

Clinical chemistry and immunoassayMolecular diagnosticsMicrobiology and blood culturePoint of care testingInstruments and automationReagents and consumables
One methodology, every sector

Sector studies follow the published Douglas Insights methodology: bottom-up models, numbered sources and confidence grades on every figure.

Read the methodology →

Answers at a glance

Questions the In-Vitro Diagnostics practice answers

How are IVD markets sized?

From test volumes multiplied by evidenced price per test, with instruments and reagents modelled separately. The installed base drives the reagent forecast, which is where most of the value sits.

Do you use tender data for pricing?

Yes. Public tenders and procurement records anchor reagent and instrument pricing, so the price line in the model reflects what laboratories actually pay.

Can you model instrument pull-through?

Yes. Placement models link instrument installed base to reagent pull-through per platform, the metric that decides IVD business cases.

Syndicated research

In-Vitro Diagnostics market research reports

All reports →

Common questions

In-Vitro Diagnostics: frequently asked questions

Does Douglas Insights cover In-Vitro Diagnostics markets?

Yes. The In-Vitro Diagnostics practice publishes syndicated market research reports and runs consulting engagements across the sector, including clinical chemistry and immunoassay, molecular diagnostics, microbiology and blood culture.

What does a In-Vitro Diagnostics market research report include?

Every report includes a ten year forecast built on a 2025 base year, segment and regional breakdowns, company profiles, an interactive fact sheet and the underlying model, with a numbered source behind each figure.

Can Douglas Insights run custom In-Vitro Diagnostics consulting?

Yes. Sector engagements cover market sizing, competitive intelligence, pricing, go-to-market and due diligence, delivered by the analysts who publish the In-Vitro Diagnostics reports on fixed fees, with proposals within 48 hours of a scope call.

How do I get a sample In-Vitro Diagnostics report?

Request a free sample from any report page or through the contact form. Samples include the table of contents, method notes and selected charts, delivered by email within 24 hours on business days.

Working on a In-Vitro Diagnostics decision?

Tell us the question. Within one business day we will map the fastest route to an answer: an existing report, a custom study or a sector consulting engagement.